Provided by Tiger Trade Technology Pte. Ltd.

Ethos Technologies Corp.

10.29
+0.04000.39%
Post-market: 10.490.2000+1.94%19:57 EST
Volume:435.72K
Turnover:4.58M
Market Cap:643.73M
PE:11.54
High:11.07
Open:10.17
Low:10.17
Close:10.25
52wk High:19.00
52wk Low:9.45
Shares:62.56M
Float Shares:10.50M
Volume Ratio:1.35
T/O Rate:4.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8920
EPS(LYR):3.05
ROE:--
ROA:--
PB:-13.16
PE(LYR):3.37

Loading ...

Company Profile

Company Name:
Ethos Technologies Corp.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
548
Office Location:
90 New Montgomery Street,Suite 1500,San Francisco,California,United States
Zip Code:
94105
Fax:
- -
Introduction:
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Directors

Name
Position
Peter Colis
Chair of the Board and Chief Executive Officer
John Kunze
Independent Director
Khozema Shipchandler
Independent Director
Lingke Wang
Director and President
Mark W. Mullin
Independent Director
Nathan J. Niparko
Independent Director
Priscilla Hung
Independent Director
Roelof Botha
Lead Independent Director
William J. Wheeler
Independent Director

Shareholders

Name
Position
Peter Colis
Chair of the Board and Chief Executive Officer
Christopher Capozzi
Chief Financial Officer
Kunal Mehta
Senior Vice President, Finance
Erin Lantz
Chief Revenue Officer
Lingke Wang
Director and President
Vipul Sharma
Chief Technology Officer